| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 48,050 | $180 | $8.6M |
| J2350 | Injection, ocrelizumab, 1 mg | 380 | $21,670 | $8.2M |
| J2323 | Injection, natalizumab, 1 mg | 1,220 | $5,540 | $6.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 31,690 | $200 | $6.4M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 20,290 | $290 | $5.9M |
| G0378 | Hospital observation service, per hour | 47,040 | $80 | $3.9M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 25,710 | $140 | $3.7M |
| 70450 | The provider performed computed tomography, or CT scanning, of the head or brain, without contrast. He performs the procedure to diagnose any brain or intracranial abnormalities. | 7,190 | $240 | $1.7M |
| 76816 | The provider reexamines the fetus to follow up on a prior abnormal transabdominal ultrasound. | 8,940 | $190 | $1.7M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 6,600 | $220 | $1.5M |